Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Morales

Showing results (721-730 of 739) with videos related to

Pageof 74
Sort By:
Clinical Neurology and Neurosurgery|December 17, 2010
The Brazilian database on pregnancy in multiple sclerosisA Finkelsztejn, Y D Fragoso, M L B Ferreira, et al.
Pediatrics|May 29, 2021
Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International ExperienceTalita Duarte-Salles, David Vizcaya, Andrea Pistillo, et al.
International Journal of Obesity (2005)|July 16, 2021
Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United KingdomMartina Recalde, Elena Roel, Andrea Pistillo, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort studyAlbert Prats-Uribe, Anthony G Sena, Lana Yin Hui Lai, et al.
Rheumatology (Oxford, England)|December 28, 2020
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Rheumatology (Oxford, England)|March 16, 2021
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
BMJ Medicine|October 13, 2023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Lovedeep Singh Dhingra, Arya Aminorroaya, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysisEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
Journal of the American College of Cardiology|August 28, 2024
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DMRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United StatesAsieh Golozar, Lana Yh Lai, Anthony G Sena, et al.
Pageof 74

Showing results (721-730 of 739) with videos related to

Sort By:
Pageof 74
Clinical Neurology and Neurosurgery|December 17, 2010
The Brazilian database on pregnancy in multiple sclerosisA Finkelsztejn, Y D Fragoso, M L B Ferreira, et al.
Pediatrics|May 29, 2021
Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International ExperienceTalita Duarte-Salles, David Vizcaya, Andrea Pistillo, et al.
International Journal of Obesity (2005)|July 16, 2021
Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United KingdomMartina Recalde, Elena Roel, Andrea Pistillo, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort studyAlbert Prats-Uribe, Anthony G Sena, Lana Yin Hui Lai, et al.
Rheumatology (Oxford, England)|December 28, 2020
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Rheumatology (Oxford, England)|March 16, 2021
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
BMJ Medicine|October 13, 2023
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DMRohan Khera, Lovedeep Singh Dhingra, Arya Aminorroaya, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysisEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
Journal of the American College of Cardiology|August 28, 2024
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DMRohan Khera, Arya Aminorroaya, Lovedeep Singh Dhingra, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United StatesAsieh Golozar, Lana Yh Lai, Anthony G Sena, et al.
Pageof 74